Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population

Detalhes bibliográficos
Autor(a) principal: Amorim, Ana Luiza M. [UNIFESP]
Data de Publicação: 2017
Outros Autores: Cabral, Nadia C. [UNIFESP], Osaku, Fabiane M. [UNIFESP], Len, Claudio A. [UNIFESP], Oliveira, Enedina M. L. [UNIFESP], Terreri, Maria Teresa [UNIFESP]
Tipo de documento: Artigo
Idioma: por
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1016/j.rbr.2016.08.004
https://repositorio.unifesp.br/handle/11600/54536
Resumo: Introduction: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are demyelinating diseases of the central nervous system. Autoimmunity in patients with demyelinating disease and in their families has been broadly investigated and discussed. Recent studies show a higher incidence of rheumatic autoimmune diseases among adult patients with MS or NMO and their families, but there are no studies in the pediatric population. Objective: To evaluate an association of MS and NMO with autoimmune rheumatic diseases in pediatric patients. Method: 22 patients younger than 21 years old with MS or NMO diagnosed before the age of 18 years were evaluated regarding epidemiological data, clinical presentation, association with autoimmune diseases, family history of autoimmune diseases, laboratory findings, imaging studies and presence of auto-antibodies. Results: Among the patients studied, there was a prevalence of females (68.1%). The mean age of symptoms onset was 8 years and 9 months and the mean current age was 16 years and 4 months. Two patients (9%) had a history of associated autoimmune rheumatic disease: one case of juvenile dermatomyositis in a patient with NMO and another of systemic lupus erythematosus in a patient with MS. Three patients (13%) had a family history of autoimmunity in first-degree relatives. ANA was found positive in 80% of patients with NMO and 52% of patients with MS. About 15% of ANA-positive patients were diagnosed with rheumatologic autoimmune disieses. Conclusion: Among patients with demyelinating diseases diagnosed in childhood included in this study there was a high frequency of ANA positivity but a lower association with rheumatologic autoimmune diseases than that observed in studies conducted in adults. (C) 2016 Elsevier Editora Ltda.
id UFSP_7d8fb45347929a45050a6afa5b3757bd
oai_identifier_str oai:repositorio.unifesp.br/:11600/54536
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Association between demyelinating disease and autoimmune rheumatic disease in a pediatric populationAutoimmune diseasesRheumatic diseasesDemyelinating diseasesChildhoodIntroduction: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are demyelinating diseases of the central nervous system. Autoimmunity in patients with demyelinating disease and in their families has been broadly investigated and discussed. Recent studies show a higher incidence of rheumatic autoimmune diseases among adult patients with MS or NMO and their families, but there are no studies in the pediatric population. Objective: To evaluate an association of MS and NMO with autoimmune rheumatic diseases in pediatric patients. Method: 22 patients younger than 21 years old with MS or NMO diagnosed before the age of 18 years were evaluated regarding epidemiological data, clinical presentation, association with autoimmune diseases, family history of autoimmune diseases, laboratory findings, imaging studies and presence of auto-antibodies. Results: Among the patients studied, there was a prevalence of females (68.1%). The mean age of symptoms onset was 8 years and 9 months and the mean current age was 16 years and 4 months. Two patients (9%) had a history of associated autoimmune rheumatic disease: one case of juvenile dermatomyositis in a patient with NMO and another of systemic lupus erythematosus in a patient with MS. Three patients (13%) had a family history of autoimmunity in first-degree relatives. ANA was found positive in 80% of patients with NMO and 52% of patients with MS. About 15% of ANA-positive patients were diagnosed with rheumatologic autoimmune disieses. Conclusion: Among patients with demyelinating diseases diagnosed in childhood included in this study there was a high frequency of ANA positivity but a lower association with rheumatologic autoimmune diseases than that observed in studies conducted in adults. (C) 2016 Elsevier Editora Ltda.Univ Fed Sao Paulo Unifesp, Dept Pediat, Setor Reumatol Pediat, Sao Paulo, SP, BrazilUniv Fed Sao Paulo Unifesp, Sao Paulo, SP, BrazilUniv Fed Sao Paulo Unifesp, Dept Neurol & Neurocirurgia, Setor Doencas Desmielinizantes, Sao Paulo, SP, BrazilUniv Fed Sao Paulo Unifesp, Dept Pediat, Setor Reumatol Pediat, Sao Paulo, SP, BrazilUniv Fed Sao Paulo Unifesp, Sao Paulo, SP, BrazilUniv Fed Sao Paulo Unifesp, Dept Neurol & Neurocirurgia, Setor Doencas Desmielinizantes, Sao Paulo, SP, BrazilWeb of ScienceElsevier Science Inc2020-07-13T11:53:19Z2020-07-13T11:53:19Z2017info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion224-228http://dx.doi.org/10.1016/j.rbr.2016.08.004Revista Brasileira De Reumatologia. New York, v. 57, n. 3, p. 224-228, 2017.10.1016/j.rbr.2016.08.0040482-5004https://repositorio.unifesp.br/handle/11600/54536WOS:000404535600007porRevista Brasileira De ReumatologiaNew Yorkinfo:eu-repo/semantics/openAccessAmorim, Ana Luiza M. [UNIFESP]Cabral, Nadia C. [UNIFESP]Osaku, Fabiane M. [UNIFESP]Len, Claudio A. [UNIFESP]Oliveira, Enedina M. L. [UNIFESP]Terreri, Maria Teresa [UNIFESP]reponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2022-02-07T21:01:42Zoai:repositorio.unifesp.br/:11600/54536Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652022-02-07T21:01:42Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
title Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
spellingShingle Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
Amorim, Ana Luiza M. [UNIFESP]
Autoimmune diseases
Rheumatic diseases
Demyelinating diseases
Childhood
title_short Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
title_full Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
title_fullStr Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
title_full_unstemmed Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
title_sort Association between demyelinating disease and autoimmune rheumatic disease in a pediatric population
author Amorim, Ana Luiza M. [UNIFESP]
author_facet Amorim, Ana Luiza M. [UNIFESP]
Cabral, Nadia C. [UNIFESP]
Osaku, Fabiane M. [UNIFESP]
Len, Claudio A. [UNIFESP]
Oliveira, Enedina M. L. [UNIFESP]
Terreri, Maria Teresa [UNIFESP]
author_role author
author2 Cabral, Nadia C. [UNIFESP]
Osaku, Fabiane M. [UNIFESP]
Len, Claudio A. [UNIFESP]
Oliveira, Enedina M. L. [UNIFESP]
Terreri, Maria Teresa [UNIFESP]
author2_role author
author
author
author
author
dc.contributor.author.fl_str_mv Amorim, Ana Luiza M. [UNIFESP]
Cabral, Nadia C. [UNIFESP]
Osaku, Fabiane M. [UNIFESP]
Len, Claudio A. [UNIFESP]
Oliveira, Enedina M. L. [UNIFESP]
Terreri, Maria Teresa [UNIFESP]
dc.subject.por.fl_str_mv Autoimmune diseases
Rheumatic diseases
Demyelinating diseases
Childhood
topic Autoimmune diseases
Rheumatic diseases
Demyelinating diseases
Childhood
description Introduction: Multiple sclerosis (MS) and neuromyelitis optica (NMO) are demyelinating diseases of the central nervous system. Autoimmunity in patients with demyelinating disease and in their families has been broadly investigated and discussed. Recent studies show a higher incidence of rheumatic autoimmune diseases among adult patients with MS or NMO and their families, but there are no studies in the pediatric population. Objective: To evaluate an association of MS and NMO with autoimmune rheumatic diseases in pediatric patients. Method: 22 patients younger than 21 years old with MS or NMO diagnosed before the age of 18 years were evaluated regarding epidemiological data, clinical presentation, association with autoimmune diseases, family history of autoimmune diseases, laboratory findings, imaging studies and presence of auto-antibodies. Results: Among the patients studied, there was a prevalence of females (68.1%). The mean age of symptoms onset was 8 years and 9 months and the mean current age was 16 years and 4 months. Two patients (9%) had a history of associated autoimmune rheumatic disease: one case of juvenile dermatomyositis in a patient with NMO and another of systemic lupus erythematosus in a patient with MS. Three patients (13%) had a family history of autoimmunity in first-degree relatives. ANA was found positive in 80% of patients with NMO and 52% of patients with MS. About 15% of ANA-positive patients were diagnosed with rheumatologic autoimmune disieses. Conclusion: Among patients with demyelinating diseases diagnosed in childhood included in this study there was a high frequency of ANA positivity but a lower association with rheumatologic autoimmune diseases than that observed in studies conducted in adults. (C) 2016 Elsevier Editora Ltda.
publishDate 2017
dc.date.none.fl_str_mv 2017
2020-07-13T11:53:19Z
2020-07-13T11:53:19Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1016/j.rbr.2016.08.004
Revista Brasileira De Reumatologia. New York, v. 57, n. 3, p. 224-228, 2017.
10.1016/j.rbr.2016.08.004
0482-5004
https://repositorio.unifesp.br/handle/11600/54536
WOS:000404535600007
url http://dx.doi.org/10.1016/j.rbr.2016.08.004
https://repositorio.unifesp.br/handle/11600/54536
identifier_str_mv Revista Brasileira De Reumatologia. New York, v. 57, n. 3, p. 224-228, 2017.
10.1016/j.rbr.2016.08.004
0482-5004
WOS:000404535600007
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv Revista Brasileira De Reumatologia
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 224-228
dc.coverage.none.fl_str_mv New York
dc.publisher.none.fl_str_mv Elsevier Science Inc
publisher.none.fl_str_mv Elsevier Science Inc
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268357322473472